| Hospital – Ref Group | Hospital - HSCT | Hospital -IBD | Hospital -SOT | Hospital Immune -Compromised | Hospital - CKD | Long Term Care | Long Term Acute Care | Community | Total |
---|---|---|---|---|---|---|---|---|---|---|
No. of Susceptible Individuals | 19,572,104 (6.13Â %) | 25,011 (0.01Â %) | 197,927 (0.06Â %) | 90,471 (0.03Â %) | 349,042 (0.11Â %) | 355,780 (0.11Â %) | 3,343,595 (1.05Â %) | 338,094 (0.11Â %) | 295,154,163 (92.40Â %) | 319,426,189 (100Â %) |
No. of Primary CDI cases | 131,114 (29.85Â %) | 1,659 (0.38Â %) | 6,897 (1.57Â %) | 2,750 (0.63Â %) | 14,282 (3.25Â %) | 13,526 (3.08Â %) | 112,152 (25.53Â %) | 6,209 (1.41Â %) | 150,648 (34.30Â %) | 439,237 (100Â %) |
No. of Recurrent CDI Cases | 65,664 (39.36Â %) | 644 (0.39Â %) | 3,128 (1.88Â %) | 1,190(0.71Â %) | 6,843 (4.10Â %) | 6,730 (4.03Â %) | 61,247 (36.71Â %) | 3,064 (1.84Â %) | 18,311 (10.98Â %) | 166,821 (100Â %) |
 1st recurrence | 36,361 (37.56 %) | 392 (0.40 %) | 1,791 (1.85 %) | 696(0.72 %) | 3,847 (3.97 %) | 3,736 (3.86 %) | 32,970 (34.06 %) | 1,705 (1.76 %) | 15,309 (15.81 %) | 96,807 (100 %) |
 2nd recurrence | 15,756 (41.17 %) | 147 (0.38 %) | 737 (1.93 %) | 278(0.73 %) | 1,630 (4.26 %) | 1,613 (4.21 %) | 14,904 (38.94 %) | 734 (1.92 %) | 2,474 (6.46 %) | 38,273 (100 %) |
 3rd recurrence | 7,096 (42.49 %) | 58 (0.35 %) | 320 (1.92 %) | 117 (0.70 %) | 722 (4.32 %) | 724 (4.34 %) | 6,910 (41.38 %) | 329 (1.97 %) | 423 (2.53 %) | 16,699 (100 %) |
 4+ recurrences | 6,452 (42.88 %) | 46 (0.31 %) | 280 (1.86 %) | 99 (0.66 %) | 645 (4.29 %) | 657 (4.37 %) | 6,464 (42.96 %) | 297 (1.97 %) | 105 (0.70 %) | 15,045 (100 %) |
Severe CDI Cases (primary + recurrent) | 19,366 (32.59 %) | 119 (0.20 %) | 790 (1.33 %) | 231 (0.39 %) | 1,805 (3.04 %) | 1,681 (2.83 %) | 23,688(39.86 %) | 875(1.47 %) | 10,876 (18.30 %) | 59,431 (100 %) |
Deaths Attributable to CDI (primary + recurrent) | 14,525 (32.59 %) | 89 (0.20 %) | 592 (1.33 %) | 173 (0.39 %) | 1,353 (3.04 %) | 1,261 (2.83 %) | 17,766 (39.86 %) | 656(1.47 %) | 8,157 (18.30 %) | 44,572 (100 %) |